Sammaan Capital Limited – Investor Presentation Summary

Key Operational Highlights

  • ₹3,875 Cr ($407 Mn) disbursed in Q1FY27 across five products to ~12,000 new customers.
  • Growth-oriented disbursals executed within defined risk guardrails.
  • Growth diversified across multiple products maintaining healthy mix of retail/wholesale and secured/unsecured.
  • 97% of Q1FY27 Disbursements are Secured Loans.
  • ₹840 Cr ($88.1 Mn) of Commercial Real-Estates loans disbursed in partnership with one of Asia's leading Alternate Credit Funds.
  • Company will pursue both Organic and Inorganic Growth opportunities.

Key drivers of operational performance: Phased product expansion, hub-and-spoke distribution network growth, and digital/AI adoption.

Segment-wise Performance

Not Specified

Financial Highlights

Revenue: Rs. 1,651.93 Cr (Total Revenue from Operations)

EBITDA: Not Specified

PAT: Rs. 243.30 Cr

EPS: Not Specified

Margins: Not Specified

YoY/QoQ comparison: Q1FY27 PAT of ₹243.30 Cr vs Q1FY26 PAT of ₹334.30 Cr (down 27.2% YoY) and vs Q4FY26 loss of ₹-8,101.41 Cr (significant turnaround).

Drivers of financial performance: Net gain on fair value changes of ₹490.98 Cr, net gain on derecognition of financial instruments of ₹24.01 Cr, and negative impairment of ₹-240.47 Cr (recovery/write-back).

Comparison to market estimates: Not Available

Key Risks: Not explicitly disclosed in the presentation.

Geographical Revenue Split

Not Specified

Balance Sheet Snapshot

Net Debt/Equity: Not Specified

Reserves: Other Equity of ₹18,912.19 Cr (Jun-26)

Current Assets/Liabilities: Current Assets include Cash and cash equivalents ₹2,705.40 Cr, Bank Balance other than cash ₹3,297.71 Cr; Current Liabilities details not fully broken out.

Working Capital/Leverage Metrics: Not Specified

Financial Health Insights: Strong liquidity position with significant cash and bank balances.

Capex & Cash Flow Health

Capital Expenditure: Not Specified

Free Cash Flow: Not Specified

Operating Cash Flow: Not Specified

Net Debt Movement: Not disclosed

Investment Rationale: Focus on capacity expansion, technology upgrades, and geographic reach.

Strategic & R&D Initiatives

Investments in Innovation: Digital and AI adoption with 53 use cases identified; Tech initiatives include Salesforce, AWS Partnership, Darwin Box, Temenos; Phased product expansion into digital personal loans, micro-LAP, rural home loans, gold loans, 2W/3W financing, retail e-commerce lending.

Expected impact on growth: AI-driven cross-sell/next-best-offer, AI-assisted loan life-cycle, productivity gains across IT, Risk, Credit & Ops, fully digitized corporate loan suite, autonomous credit decisioning.

Strategic Rationale: Expanding into high-growth markets and products, reducing operational costs through digitalization, balancing growth and risk with a secured-loan focus.

Industry Trends & Business Environment

Macro/Industry Trends: Not explicitly detailed.

Impact on Company: Not explicitly detailed.

Management Commentary & Growth Outlook

Strategic Outlook: "Clear Path to Growth" with defined targets for ratings, cost of funds, disbursals, and network expansion.

FY Guidance: Disbursals target of ~₹20,000 Cr ($2.1 Bn) in H2FY27; ₹40,000 to ₹50,000 Cr ($4.2 Bn to $5.2 Bn) in FY28; ₹50,000 to ₹92,000 Cr per year ($5.2 Bn to 9.6 Bn) in FY29-30. Cost of Funds target: incremental CoF to decline from 10.5-9.0% in H1FY27 to 7.8-7.2% by FY29-30; stock CoF from ~10.5-9.6% to 8.9-7.8%. Branch expansion target: from ~270 in FY27 to ~700-800 in FY28 and ~1,100-1,600 by FY30. Manpower target: from ~8,000 in FY27 to ~10,000-12,500 in FY28 and ~16,500-20,000 by FY30.

Market Share Targets: Not Available

Risks and Opportunities: Not explicitly highlighted.

Governance Update

  • Mr. Subhash Sheoratan Mundra (Chairman) completes his term on August 17, 2026.
  • Mr. Dinabandhu Mohapatra will be Interim Chairman from August 18, 2026.
  • Process of onboarding a Big-5 firm as Statutory auditor and Internal Audit co-sourcing partner.
  • New Independent Directors to be appointed to further strengthen the Board.
  • Defined AI governance framework with Board & Management risk oversight.

Shareholding Pattern

  • Avenir (IHC) current stake is 28.5%; this is to increase to ~43.5% upon ~₹3,198 Cr warrant infusion, subject to conversion by 30th Sept, 2027.